Hong Kong Pharma Digital Technology Holdings Limited (HKPD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 9.22M | 11.09M | 9.68M |
| Revenue Growth % | -4.72% | - | - |
| Cost of Goods Sold | 8.71M | 9.19M | 7.46M |
| COGS % of Revenue | 94.47% | 82.82% | 77.04% |
| Gross Profit | 509.56K | 1.91M | 2.22M |
| Gross Margin % | 5.53% | 17.18% | 22.96% |
| Gross Profit Growth % | -77.07% | - | - |
| Operating Expenses | 1.4M | 878.57K | 923.23K |
| OpEx % of Revenue | 15.23% | 7.92% | 9.54% |
| Selling, General & Admin | 1.33M | 881.12K | 894.68K |
| SG&A % of Revenue | 14.47% | 7.94% | 9.24% |
| Research & Development | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 69.81K | -2.55K | 28.56K |
| Operating Income | -895K | 1.03M | 1.3M |
| Operating Margin % | -9.7% | 9.26% | 13.43% |
| Operating Income Growth % | -168.88% | - | - |
| EBITDA | -853.29K | 1.06M | 1.33M |
| EBITDA Margin % | -9.25% | 9.57% | 13.76% |
| EBITDA Growth % | -164.06% | - | - |
| D&A (Non-Cash Add-back) | 41.71K | 34.05K | 32.51K |
| EBIT | -835.04K | 1.03M | 1.33M |
| Net Interest Income | -47.75K | -48.18K | -47.64K |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 47.75K | 48.18K | 47.64K |
| Other Income/Expense | -47.75K | -48.17K | -47.64K |
| Pretax Income | -942.75K | 978.86K | 1.25M |
| Pretax Margin % | -10.22% | 8.83% | 12.93% |
| Income Tax | 87.14K | 150.3K | 171.12K |
| Effective Tax Rate % | -9.24% | 15.35% | 13.67% |
| Net Income | -855.62K | 828.56K | 1.08M |
| Net Margin % | -9.28% | 7.47% | 11.16% |
| Net Income Growth % | -179.17% | - | - |
| Net Income (Continuing) | -1.03M | 828.56K | 1.08M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | -0.08 | 0.08 | 0.11 |
| EPS Growth % | -176.48% | - | - |
| EPS (Basic) | -0.08 | 0.08 | 0.11 |
| Diluted Shares Outstanding | 10.41M | 10M | 10M |
| Basic Shares Outstanding | 10.35M | 10M | 10M |
| Dividend Payout Ratio | - | - | - |